What We're Reading: Page 285
Industry reads hand-picked by our editors
Feb 27, 2018
-
MarketWatch
This could be the next $1 billion drug, if patients get on board
-
Chemical & Engineering News
Senti launches to improve cell therapies with synthetic gene circuits
-
Healthcare Dive
Apple to launch primary care clinics for employees, CNBC reports
Feb 26, 2018
-
CNBC
Buffett: Bezos, Dimon aim for something bigger on health than just shaving costs
-
The Wall Street Journal
Hidden profits in the prescription drug supply chain
-
The New York Times
Why your pharmacist can’t tell you that $20 prescription could cost only $8
-
MarketWatch
Expect better, more reliable flu tests
-
TechCrunch
What does it take to be a startup that raises huge sums quickly?
Feb 23, 2018
-
The Guardian
Hunt to crack down on NHS drug errors linked to up to 22,000 deaths
-
Medical Marketing & Media
Why Facebook's algorithm change may benefit patient influencers
-
The Sacramento Bee
'Hundreds of thousands of pills.' Opioid prescriptions send Granite Bay cardiologist to prison
Feb 22, 2018
Feb 21, 2018
Feb 20, 2018
-
The Boston Globe
2 pharma giants, Calif. hospital to use Boston firm’s ‘organ-on-a-chip’ to develop drugs
-
NPR
Did pox virus research put potential profits ahead of public safety?
-
Chemical & Engineering News
Japanese firms push into cell therapy
-
Retail Dive
Chinese pharma company grabs major stake in GNC
-
The New York Times
Doctors said immunotherapy would not cure her cancer. They were wrong.
Previous
